These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 26699544)

  • 1. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma.
    Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF
    BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
    Li C; Cai S; Wang X; Jiang Z
    Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine threonine tyrosine kinase 1 is a potential prognostic marker in colorectal cancer.
    Hu L; Chen HY; Cai J; Zhang Y; Qi CY; Gong H; Zhai YX; Fu H; Yang GZ; Gao CF
    BMC Cancer; 2015 Apr; 15():246. PubMed ID: 25884558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of carbonic anhydrase VII expression in colorectal carcinoma.
    Yang GZ; Hu L; Cai J; Chen HY; Zhang Y; Feng D; Qi CY; Zhai YX; Gong H; Fu H; Cai QP; Gao CF
    BMC Cancer; 2015 Apr; 15():209. PubMed ID: 25885898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance.
    Hu L; Chen HY; Han T; Yang GZ; Feng D; Qi CY; Gong H; Zhai YX; Cai QP; Gao CF
    Tumour Biol; 2016 Jan; 37(1):837-45. PubMed ID: 26254099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer.
    Shen X; Bai Y; Luo B; Zhou X
    Biol Res; 2017 Oct; 50(1):32. PubMed ID: 28969673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
    Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
    Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of ROR2 in cancer cell correlates with unfavorable prognosis in colorectal cancer.
    Mei H; Lian S; Zhang S; Wang W; Mao Q; Wang H
    Biochem Biophys Res Commun; 2014 Oct; 453(4):703-9. PubMed ID: 25301559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
    Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
    Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
    Gao JY; Song BR; Peng JJ; Lu YM
    World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Rab27A expression indicates favorable prognosis in CRC.
    Shi C; Yang X; Ni Y; Hou N; Xu L; Zhan F; Zhu H; Xiong L; Chen P
    Diagn Pathol; 2015 Jun; 10():68. PubMed ID: 26070933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
    Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
    Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of SULT2B1b is an independent prognostic indicator and promotes cell growth and invasion in colorectal carcinoma.
    Hu L; Yang GZ; Zhang Y; Feng D; Zhai YX; Gong H; Qi CY; Fu H; Ye MM; Cai QP; Gao CF
    Lab Invest; 2015 Sep; 95(9):1005-18. PubMed ID: 26121319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Expression of DLG1 Is Associated with Poor Prognosis in Patients with Colorectal Cancer.
    Zhu GD; OuYang S; Liu F; Zhu ZG; Jiang FN; Zhang B
    Ann Clin Lab Sci; 2017 Nov; 47(6):657-662. PubMed ID: 29263038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
    Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
    Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.
    Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z
    Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
    Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
    Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nemo‑like kinase expression predicts poor survival in colorectal cancer.
    Chen J; Han Y; Zhao X; Yang M; Liu B; Xi X; Xu X; Liang T; Xia L
    Mol Med Rep; 2015 Feb; 11(2):1181-7. PubMed ID: 25371216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.